ecopipam has been researched along with quinoxalines in 1 studies
Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
---|---|---|---|---|---|
147 | 18 | 34 | 9,887 | 625 | 3,095 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunney, BS; Shi, WX; Zhang, XX; Zheng, P | 1 |
1 other study(ies) available for ecopipam and quinoxalines
Article | Year |
---|---|
Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzazepines; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Membrane Potentials; Prefrontal Cortex; Pyramidal Cells; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1999 |